Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P100016/S028

CT LUCIA Intraocular Lenses (IOLs)

Carl Zeiss Meditec Production, LLC · Decision date Oct 23, 2026

MEDTECHLEDGER EXPLANATIONP100016/S028

What did the FDA decide?

FDA database record P100016/S028, dated 2026-10-23, is a 30-Day Notice for CT LUCIA intraocular lenses from Carl Zeiss Meditec Production, LLC. The decision field reads OK30. The statement describes changes to the tray raw material and lid coating for the CT LUCIA 621P IOL, plus a sterilization process change removing the ambient aeration step from the ethylene oxide sterilization process for CT LUCIA 202, CT LUCIA 602, and CT LUCIA 621P IOLs.

The supplement type is a 30-Day Notice and the supplement reason is Process Change - Manufacturer/Sterilizer/Packager/Supplier. This is not a new approval of the original PMA system. The record does not state whether the changes affect safety or clinical effectiveness. No clinical outcome data, trial information, or indication changes appear in the supplied fields.

FDA approval order statement

changes to the tray raw material and lid coating for CT LUCIA 621P Intraocular lens (IOL) and a sterilization process change involving the removal of the ambient aeration step from the Ethylene Oxide (EO) sterilization process for CT LUCIA 202, CT LUCIA 602, and CT LUCIA 621P IOLs
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Ophthalmic
Decision date
Oct 23, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P100016/S028
Regulatory pathway
PMA supplement
Product code
HQL
Decision code
OK30
Decision date
Oct 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: intraocular lens.

Product code
HQL
FDA device class
3

For the original device and its historical approval scope, see PMA P100016. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P100016 · Original PMA

    EC-3 INTRAOCULAR LENS (IOL) AND EC-3 PRECISION ASPHERIC LENS (PAL) IOL

  2. P100016/S028 received

    Application receipt date recorded by FDA.

  3. P100016/S028 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P100016. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P100016

Product / regulatory recordCompanyPathwayDecision dateSource
Carl Zeiss Meditec Production, LLCPMA approvalOct 19, 2010FDA

Explore the linked device profile

Other records with product code HQL

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Carl Zeiss Meditec Production, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1040 S. Vintage Ave., Bldg. A, Ontario, CA, 91761

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records